Table 1.
Clinicopathological features of undifferentiated pleomorphic sarcoma in cases retrieved from the PubMed database4,5,8,11,18-34
| Data | Value (n=33) |
|---|---|
| Sex | |
| Male | 19 (57.6) |
| Female | 14 (42.4) |
| Mean age (yr) | 50.5±19.7 |
| Site | |
| Maxilla | 10 (30.3) |
| Mandible | 23 (69.7) |
| Signs/symptoms | |
| Swelling | 14 (42.4) |
| Pain | 10 (30.3) |
| Ulcer | 4 (12.1) |
| Growth or mass | 14 (42.4) |
| Numbness | 4 (12.1) |
| Cervical lymph node involvement | |
| Yes | 5 (15.2) |
| No | 11 (33.3) |
| Non-contributory | 17 (51.5) |
| Radiation-induced UPS | |
| Yes | 7 (21.2) |
| No | 26 (78.8) |
| Treatment | |
| QT+surgery | 4 (12.1) |
| RT+surgery | 6 (18.2) |
| RQT+surgery | 1 (3.0) |
| Surgery | 21 (63.6) |
| QT | 1 (3.0) |
| Follow-up | |
| Living1 | 14 (42.4) |
| Dead2 | 14 (42.4) |
| Unknown | 5 (15.2) |
(UPS: undifferentiated pleomorphic sarcoma, QT: chemotherapy, RT: radiotherapy, RQT: radiotherapy and chemotherapy)
Mean follow-up length: 1Living, 40.7 months; 2Dead, 12 months.
Values are presented as number (%) or mean±standard deviation.